Debio 0123, Debio 0123, Debio 0123, Debio 2513, Debio 0123, Debio 2513, Debio 0123, Debio 0123
Debio 0123-106
Phase 1 small_molecule active
Quick answer
Debio 0123, Debio 0123, Debio 0123, Debio 2513, Debio 0123, Debio 2513, Debio 0123, Debio 0123 for Advanced solid tumors with CCNE1 amplification or deleterious mutations in FBXW7 or other proprietary gene is a Phase 1 program (small_molecule) at Pharm Research Associates (UK) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharm Research Associates (UK) Limited
- Indication
- Advanced solid tumors with CCNE1 amplification or deleterious mutations in FBXW7 or other proprietary gene
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active